![Frank Shannon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank Shannon
Director Técnico/Científico/I+D en SERNOVA CORP. .
Cargos activos de Frank Shannon
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SERNOVA CORP. | Director Técnico/Científico/I+D | 30/06/2021 | - |
Consejero General | 30/06/2021 | - |
Historial de carrera de Frank Shannon
Antiguos cargos conocidos de Frank Shannon.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ripple Therapeutics Corp. | Consejero General | - | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Ciba-Geigy Corp. | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - | - |
TEARLAB CORPORATION | Corporate Officer/Principal | - | - |
i3 Innovus | Corporate Officer/Principal | - | - |
Interface Biologics, Inc.
![]() Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 15/10/2009 | 15/10/2009 |
Estadísticas
Internacional
Estados Unidos | 7 |
Canadá | 4 |
Operativa
Corporate Officer/Principal | 7 |
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 7 |
Technology Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SERNOVA CORP. | Health Technology |
Empresas privadas | 8 |
---|---|
Interface Biologics, Inc.
![]() Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Technology Services |
i3 Innovus | Finance |
TearLab Corporation, Inc.
![]() TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Ciba-Geigy Corp. | Health Technology |
Ripple Therapeutics Corp. |
- Bolsa de valores
- Insiders
- Frank Shannon
- Experiencia